Human and economic burden of generalized anxiety disorder

	Tweet

The goal of the current work is to provide a comprehensive review and interpretation of the literature on the human and economic burden of generalized anxiety disorder (GAD) and how it compares with that of other mental disorders. The term human burden is used to describe quantified impairments in role functioning and quality of life (QOL).

Economic burden describes costs related to health care resource utilization and lost work. A review of 34 studies reporting original quantitative data on associations between GAD and role functioning, QOL, and/or economic costs was undertaken. GAD was defined by DMS-III-R, DSM-IV, or ICD-10 DCR.

Persons with GAD (both with and without a comorbid mental disorder) described significant impairments due to both physical and emotional problems.

Studies typically showed that role and QOL impairments of GAD were at least comparable in magnitude to those of other anxiety disorders, somatoform disorders, and physical conditions, and greater than those of substance use disorders.

Large representative studies showed that role impairments of pure GAD were similar in magnitude to those of pure MDD. Studies of DSM-IV disorders showed that QOL impairments of GAD were at least comparable in magnitude to those of MDD; studies of DSM-III-R disorders showed the opposite pattern.

GAD was associated with considerable economic costs owing to lost work productivity and high medical resource use. Quality of care initiatives that have been implemented to increase recognition and improve treatment outcomes for persons with MDD should be extended to the effective management of GAD.

Depression Anxiety 0:1-19, 2006. © 2006 Wiley-Liss, Inc.

Deborah L. Hoffman, Ph.D. *, Ellen M. Dukes, Ph.D., Hans-Ulrich Wittchen, Ph.D.

Independent Outcomes Research Consultant, New Haven, Connecticut
Pfizer, Inc., New York, New York
Institute for Clinical Psychology and Psychotherapy, Dresden University of Technology, Dresden, Germany
email: Deborah L. Hoffman (.)

* Correspondence to Deborah L. Hoffman, Deborah Hoffman, 436 Orange St., New Haven CT 06511

Keywords
anxiety disorders • quality of life • disability evaluation • costs and cost analysis • economics • medical • review

RELATED STORIES:
Severe trauma affects kids’ brain function, say Stanford/Packard researchers   Poor sleep is independently associated with depression in postpartum women   Antidepressants Help Men Decrease Alcohol Consumption, but Not Women   Valproic acid may help slow the progression of dementia   Genetic roots of bipolar disorder revealed by first genome-wide study of illness   Are Older Antidepressants Better for Depression in Parkinson’s Disease?   Work/family conflicts more likely in mentally ill   Sexualization of Girls Is Linked to Common Mental Health Problems in Girls and Women-Eating Disorder   New moms, dads show increased depression risk   Lung disease linked to mental health problems   Rat race Hong Kong comes to terms with depression   Minimum drinking age of 21 saves lives   Black gay men, lesbians, have fewer mental disorders than whites, says Mailman School of PH study   Antidepressants don’t affect post-birth weight loss   Children With Autistic Traits Remain Undiagnosed

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]